Filing Details

Accession Number:
0001127602-24-001438
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-17 16:41:14
Reporting Period:
2024-01-16
Accepted Time:
2024-01-17 16:41:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492422 Apellis Pharmaceuticals Inc. APLS Pharmaceutical Preparations (2834) 271537290
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1856078 Jeffrey Mark Delong C/O Apellis Pharmaceuticals, Inc.
100 Fifth Avenue, 3Rd Floor
Waltham MA 02451
Chief Business & Strat Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-01-16 16,963 $0.00 68,585 No 4 A Direct
Common Stock Disposition 2024-01-16 1,631 $66.81 66,954 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2024-01-16 24,666 $66.30 24,666 $66.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
24,666 2034-01-15 No 4 A Direct
Footnotes
  1. This represents an award of Restricted Stock Units granted 01/16/2024 that vests annually from grant date over a four year period subject to continued service.
  2. This represents shares sold to cover tax withholding on the Restricted Stock Units released on 01/12/2024.
  3. This represents a stock option award granted 01/16/2024 that vests over a four year period. 25% vests one year from grant date and the remaining 75% vests monthly thereafter subject to continued service.